Scientific Program

Wednesday, October 25, 2017
08:15-08:45 Breakfast & coffee
09:00-11:00 Session 1: Future of Reproductive Medicine
09:00-09:20 Welcome address:
John Zhang, USA
09:20-09:45 Welcome to The Brave New World of ART:
Genetic Modifications, Manufactured Gametes and Exotic Inheritance
Gerald Schatten, USA
09:45-10:10 Telomere Length and Fertility
David Keefe, USA
10:10-10:35 Mitochondria, growth hormone, and embryo quality: A new perspective of IVF
Xiaoyan Liang, China
10:35-11:00 Single Cell Whole Genome Amplification Technologies and the Future of Chromosome Screening
Sunney Xie, China
11:00-11:30 Coffee Break
11:30-13:00 Session 2: Fertility cryopreservation
11:30-12:00 Oocyte Versus Ovarian Tissue Cryopreservation
Sherman Silber, USA
12:00-12:30 Universal Embryo Cryopreservation: Frozen Versus Fresh Transfer
Zaher Merhi, USA
12:30-13:00 Oocyte and Ovarian Cryopreservation
Kutluk Oktay, USA
13:00-13:45 Lunch Break
13:45-14:00 Physicians Perspective on Fertility Preservation – Result of a Survey Done by IVF-Worldwide
Milton Leong, Hong Kong & Zeev Shoham, Israel
14:00-14:30 How to Preserve the Ovarian Reserve in Women with Endometriomas: From Surgery to Oocytes and Ovarian Tissue Freezing
Jacques Donnez, Belgium
14:30-15:20 Session 3: Egg health
14:30-14:55 Oocyte Quality in Natural Cycle vs COH Cycle
Keiichi Kato, Japan
14:55-15:20 HER IVF for Oocyte Reconstruction: Rejuvenation for Aged Oocyte
Liu Hui, USA
15:20-15:40 Coffee Break
15:40-17:00 Session 4: Embryo health
15:40-16:00 HER IVF for Oocyte Reconstruction: Prevention of Transmission of Mitochondrial Mutation
John Zhang, USA
16:00-16:30 Mitochondriacs: Is this an Anxiety Disorder Resulting from what We Know, What We Know We Don’t Know and What We Don’t Know That We Don’t Know About Mitochondria?
Gerald Schatten, USA
16:30-17:00 Genetical markers of early embryo arrest
Valery Zukin, Ukraine


Thursday, October 26, 2017
08:15-08:45 Breakfast & coffee
09:00-10:30 Session 5: Protocols for Preparation for Egg Collection
09:00-09:30 In Vitro Activation: A New Infertility Treatment for Patients with Primary Ovarian Insufficiency (POI)
Kazuhiro Kawamura, Japan
09:30-10:00 Clinical Management for Low Ovarian Reserve
Yanping Kuang, China
10:00-10:30 Primordial Follicle Recruitment and Ovarian Reserve
Sherman Silber, USA
10:30-11:00 Coffee Break
11:00-12:30 Session 6: implantation
11:00-11:30 Endometrial Preparation
Zitao Liu, USA
11:30-12:00 How to Make the Best Use of the Natural Cycle for Frozen-Thawed Embryo Transfer?
Ariel Weissman, Israel
12:00-12:30 The Place of Surgical Approaches in the Management of Myomas Related Infertility
Jacques Donnez, Belgium
12:30-13:15 Lunch Break
13:15-14:15 Session 7: Special Session
13:15-13:45 Clinical ICSI in the horse: differences and similarities to human in an in vitro maturation-based system
Katrin Hinrichs, USA
13:45-14:15 How do we interpreted the results of PGS
Santiago Munne, USA
14:15-15:15 Session 8: Innovation in the field of reproduction
14:15-14:45 Contextualizing Reproductive Strategies when Building a Mammalian Ovary
David Albertini, USA
14:45-15:15 The Artificial Ovary: Tips and Tricks
Marie-Madeleine Dolmans, Belgium
15:15-15:45 Coffee break
15:45-17:00 Session 9: Nuclear transfer and ovarian aging
15:45-16:10 Nuclear Transfer: Clinical Application
John Zhang, USA
16:10-16:35 Comparison of the methods of nuclear transfer (GV, spindle, pronuclei)
Pavlo Mazur, Ukraine
16:35-17:00 Potential Molecular Targets for Treating Ovarian Aging
Kutluk Oktay, USA
17:00 Closing Remarks
John Zhang, USA
back to top